**Abstract**

The full range of glycoconjugates made up of glycans, or carbohydrate chains, that are covalently joined to lipid or protein molecules is known as the glycome. Glycoconjugates are created, through the process of glycosylation (vary in length, glycan sequence, and the connections that connect them). The creation of therapies can now take advantage of new knowledge about the structure and operation of the glycome, which may enhance our capacity to control inflammation and immune responses, maximize the efficacy of therapeutic antibodies, and enhance immune responses to cancer. These instances highlight the promise of the young discipline of "glycomedicine." The prevalence of glycoconjugates in nature and their significance in various biological processes have prompted the development of numerous synthesizing techniques for these molecules. Today, synthetic glycoconjugates are utilized to address a wide range of biological concerns linked to glycoconjugates. This study seeks to update earlier reviews on the topic as well as gather and compile the most recent developments in the fields of glycopeptide, glycoprotein, and glycolipid synthesis. Finally, we hope that this study may stimulate fruitful research in this significant area of medicinal chemistry by highlighting the triumphs and shortcomings of prior research.

**Keywords:** Glycoconjugates, N-linked glycosylation, O-linked glycans, C-linked glycans, pharmacological activity, pharmaceutical activity
